Project Profile

A 56-WEEK RANDOMIZED, MULTI-CENTER, DOUBLE BLINDED, PLACEBO-CONTROLLED PHASE IIA/IIB STUDY TO EVALUATE THE SAFETY AND EFFICACY OF I.V. BIMAGRUMAB ....

Keyword Search